{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:17:45Z","timestamp":1789132665820,"version":"build-2803163510"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 64-year-old woman with a history of weight loss and a markedly elevated serum carbohydrate antigen 19-9 level of 560 U\/mL was referred for an <jats:sup>18<\/jats:sup>F-FDG PET study to evaluate for occult malignancy. In addition to the weight loss, she had suffered from a chronic cough secondary to bronchiectasis and had been investigated for a suspected gastrointestinal malignancy. Multiple FDG-avid foci were detected throughout both lungs on FDG PET, corresponding to areas of bronchiectasis on CT with no obvious suspicious FDG-avid foci elsewhere. This supported an inflammatory process causing her elevated carbohydrate antigen 19-9 rather than malignancy.<\/jats:p>","DOI":"10.1097\/rlu.0000000000001965","type":"journal-article","created":{"date-parts":[[2017,12,30]],"date-time":"2017-12-30T13:13:28Z","timestamp":1514639608000},"page":"207-208","source":"Crossref","is-referenced-by-count":4,"title":["Bronchiectasis as a Cause of Elevated CA-19-9 Demonstrated on 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"43","author":[{"given":"Paul","family":"Mikhail","sequence":"first","affiliation":[{"name":"From the *Department of Nuclear Medicine and PET, Nepean Hospital Penrith, Penrith, New South Wales; and \u2020Sydney Medical School Nepean, University of Sydney, Kingswood, New South Wales, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Le","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine and PET, Nepean Hospital Penrith, Penrith, New South Wales; and \u2020Sydney Medical School Nepean, University of Sydney, Kingswood, New South Wales, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuong","family":"Bui","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine and PET, Nepean Hospital Penrith, Penrith, New South Wales; and \u2020Sydney Medical School Nepean, University of Sydney, Kingswood, New South Wales, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Mansberg","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine and PET, Nepean Hospital Penrith, Penrith, New South Wales; and \u2020Sydney Medical School Nepean, University of Sydney, Kingswood, New South Wales, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231021","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-94-017-7215-0_15","article-title":"CA 19-9: biochemical and clinical aspects","volume":"867","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"bib2-20231021","first-page":"88","article-title":"Serum CA 19-9 as a biomarker for pancreatic cancer\u2014a comprehensive review","volume":"2","year":"2001","journal-title":"Indian J Surg Oncol"},{"key":"bib3-20231021","first-page":"1369","article-title":"CA 19-9: handle with care","volume":"51","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"bib4-20231021","first-page":"750","article-title":"Increased CA 19-9 level in patients without malignant disease","volume":"47","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"bib5-20231021","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12885-016-2897-6","article-title":"The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma","volume":"16","year":"2016","journal-title":"BMC Cancer"},{"key":"bib6-20231021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jcla.20136","article-title":"Serum Levels of CA19-9 in patients with nonmalignant respiratory diseases","volume":"21","year":"2007","journal-title":"J Clin Lab Anal"},{"key":"bib7-20231021","first-page":"78","article-title":"Increased serum CA 19.9 in bronchiectasis [in French]","volume":"25","year":"2008","journal-title":"Rev Mal Respir"},{"key":"bib8-20231021","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4046\/trd.2008.64.5.383","article-title":"A case of bronchiectasis with high serum CA19-9","volume":"64","year":"2008","journal-title":"Tuberc Respir Dis"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201803000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T04:04:18Z","timestamp":1697861058000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201803000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001965","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}